Pazopanib in advanced soft tissue sarcomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pazopanib in advanced soft tissue sarcomas

Published:2019-05-17 Issue:1 Volume:4 Page:
ISSN:2059-3635
Container-title:Signal Transduction and Targeted Therapy
language:en
Short-container-title:Sig Transduct Target Ther

Author:

Lee Alex T. J.,Jones Robin L.,Huang Paul H.

Funder

Institute of Cancer Research, Royal Cancer Hospital

Sarcoma UK

Royal Marsden NHS Foundation Trust

As above

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics

Link

http://www.nature.com/articles/s41392-019-0049-6.pdf

Reference80 articles.

1. Kitagawa, D. et al. Activity-based kinase profiling of approved tyrosine kinase inhibitors. Genes Cells 18, 110–122 (2013).

2. Ku, X., Heinzlmeir, S., Helm, D., Médard, G. & Kuster, B. New affinity probe targeting VEGF receptors for kinase inhibitor selectivity profiling by chemical proteomics. J. Proteome Res. 13, 2445–2452 (2014).

3. Kumar, R. et al. Pharmacokinetic–pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity. Mol. Cancer Ther. 6, 2012–2021 (2007).

4. Noujaim, J., Payne, L. S., Judson, I., Jones, R. L. & Huang, P. H. Phosphoproteomics in translational research: a sarcoma perspective. Ann. Oncol. 27, 787–794 (2016).

5. Podar, K. et al. The small-molecule VEGF receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myeloma. Proc. Natl Acad. Sci. USA 103, 19478–19483 (2006).

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges in the Management of Recurrent CNS Solitary Fibrous Tumors: A Case Report;Cureus;2024-09-04

2. Total management of hemangiopericytoma/solitary fibrous tumor of the buttock: A case report;Medicine;2024-07-19

3. Clinical course and vascular endothelial growth factor signaling system expression in maxillary angiosarcoma: A case report;Science Progress;2024-07

4. Metastatic malignant glomus tumor resistant to pazopanib, a multikinase inhibitor: A case report and review of literature;JOS Case Reports;2024-07

5. Efficacy of Pazopanib on Primary Patient-derived Undifferentiated Malignant Round Cell Sarcoma Line;Advances in Human Biology;2024-06-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3